Cite
HARVARD Citation
Arndt, C. et al. (2014). Simultaneous targeting of prostate stem cell antigen and prostate‐specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell‐retargeting system. Prostate. 74 (13), pp. 1335-1346. [Online].